Sociodemographic Variation in Early Uptake of COVID-19 Vaccine and Parental Intent and Attitudes Toward Vaccination of Children Aged 6 Months–4 Years — United States, July 1–29, 2022

MMWR Morbidity and Mortality Weekly Report, Journal Year: 2022, Volume and Issue: 71(46), P. 1479 - 1484

Published: Nov. 17, 2022

COVID-19 vaccines are safe and effective for infants young children, on June 18, 2022, CDC recommended vaccination children (children) aged 6 months-4 years (1,2).As of November 9, based administrative data reported to CDC,* 5.9% <2 8.8% 2-4 had received ≥1 dose.To better understand reasons low coverage among <5 years, analyzed from 4,496 National Immunization Survey-Child COVID Module (NIS-CCM) interviews conducted during July 1-29, examine variation in receipt dose vaccine parental intent vaccinate by sociodemographic characteristics beliefs about COVID-19; type place was also reported.Among 3.5% were vaccinated; 59.3% unvaccinated, but the parent open vaccination; 37.2% reluctant their child.Openness higher parents Hispanic or Latino (Hispanic) (66.2%), non-Hispanic Black African American (Black) (61.1%), Asian (Asian) (83.1%) than White (White) (52.9%) lower rural areas (45.8%) urban (64.1%).Parental confidence safety a provider recommendation unvaccinated vaccinated children.COVID-19 recommendations health care provider, along with dissemination information trusted persons, could increase children.NIS-CCM † is an ongoing, national random-digit-dialed mobile telephone survey households that include adolescents months-17 (3,4).The respondent guardian (parent) who indicated they knowledgeable child's history.COVID-19 status parent's * Reported estimates single year age and, despite targeting months population all used as denominator.https://covid.cdc.gov/covid-data-tracker/#vaccination-demographic;https:// covid.cdc.gov/covid-data-tracker/#vaccination-demographics-trends

Language: Английский

---

An overview of the COVID-19 pediatric vaccine program – The U.S. experience vaccinating children ages 6 months through 17 years

Vaccine, Journal Year: 2024, Volume and Issue: 42, P. 125702 - 125702

Published: Feb. 29, 2024

COVID-19 vaccination decreases risk for illness and severe disease in children, including multisystem inflammatory syndrome (MIS-C) death. On December 13, 2020, CDC recommended persons ages ≥16 years, with expansion on May 12, 2021, to adolescents 12-15 years; children 5-11 years November 2, 2021; 6 months-4 June 18, 2022. Following each age-specific recommendation, the U.S. government collaborated state local governments, vaccine manufacturers, numerous other public private entities, ensure rapid, broad, equitable distribution strategic locations across country maximize access. However, coverage among has been lower than adults younger adolescents. As of 10, 2023, primary series was 61.8% 12-17 32.9% those 5.5% years. This manuscript describes planning implementation pediatric program, successes (e.g., availability pharmacy extend access beyond more traditional providers) challenges multi-dose vials instead single-dose vials, leading concerns about wastage) provide a historical record program help inform future routine or pandemic-related campaigns.

Language: Английский

---

Neutralization of SARS-CoV-2 Omicron BQ.1, BQ.1.1 and XBB.1 variants following SARS-CoV-2 infection or vaccination in children

Nature Communications, Journal Year: 2023, Volume and Issue: 14(1)

Published: Dec. 1, 2023

Emergence of highly transmissible Omicron subvariants led to increased SARS-CoV-2 infection and disease in children. However, minimal knowledge exists regarding the neutralization capacity against circulating BA.4/BA.5, BA.2.75, BQ.1, BQ.1.1 XBB.1 following vaccination children versus during acute or convalescent COVID-19, multisystem inflammatory syndrome (MIS-C). Here, we evaluate virus-neutralizing variants 151 age-stratified ( <5, 5-11, 12-21 years old) hospitalized with severe COVID-19 MIS-C mild (outpatient) compared 62 vaccinated An age-associated effect on neutralizing antibodies is observed vaccination. The primary series BNT162b2 mRNA adolescents show higher vaccine-homologous WA-1 titers <12 Post-infection did not neutralize subvariants. In contrast, monovalent induces more cross-neutralizing young <5 ≥5 old Our study demonstrates that children, vaccination-induced activity low variants. These findings suggest a need for improved vaccines induce durable, cross-reactive provide effective protection emerging

Language: Английский

---

Evolution of the Antigenic Landscape in Children and Young Adults with COVID-19 and MIS-C

Vaccines, Journal Year: 2024, Volume and Issue: 12(6), P. 638 - 638

Published: June 7, 2024

There is minimal knowledge regarding the durability of neutralization capacity and level binding antibody generated against highly transmissible circulating Omicron subvariants following SARS-CoV-2 infection in children with acute COVID-19 those diagnosed multisystem inflammatory syndrome (MIS-C) absence vaccination. In this study, titers ancestral strain (WA1) sublineages were evaluated unvaccinated admitted for (n = 32) MIS-C at time hospitalization (baseline) six to eight weeks post-discharge (follow-up) between 1 April 2020, September 2022. addition, spike receptor domain (RBD) from WA1, BA.1, BA.2.75, BA.4/BA.5 was determined using surface plasmon resonance (SPR). At baseline, demonstrated two-fold three-fold higher neutralizing antibodies WA1 compared COVID-19. Importantly, COVID-19, virus reached same as had baseline but than 6–8 cases. Cross-neutralization recently emerged BQ.1, BQ.1.1, XBB.1 variants very low either or all points. These findings about post-infection immunity suggest need vaccinations prior provide effective protection emerging variants.

Language: Английский

---

Vaccines for Children Provider Practices in the COVID-19 Vaccination Program: Barriers to Participation, Intentions to Offer COVID-19 Vaccination to Children Aged <5 Years, and Vaccination Promotion, United States, March 2022

Clinical Pediatrics, Journal Year: 2023, Volume and Issue: 62(12), P. 1479 - 1488

Published: March 15, 2023

The aim of the study was to assess barriers Vaccines for Children (VFC) provider practices participating in COVID-19 Vaccination Program and intentions offer vaccination children aged <5 years. We invited a random sample 15 000 VFC United States complete an online survey during February 28 March 11, 2022. Of 2809 that completed survey, 2246 (80.0%) were enrolled Program. Concerns around staff resources, vaccine supply storage space, wastage from multidose vials most frequently reported program-enrollment barriers. Among have decided whether years, 1641 (88.8% 1848) likely offering it current patients, 1165 who are not patients. Addressing participation encouraging active promotion may increase coverage children.

Language: Английский

---

A survey of state and local practices encouraging pediatric COVID-19 vaccination of children ages 6 months through 11 years

Vaccine, Journal Year: 2024, Volume and Issue: 42, P. 125837 - 125837

Published: April 9, 2024

This report highlights state and local practices for optimizing the pediatric COVID-19 vaccination program children ages 6 months through 11 years.

Language: Английский

---

Implementation of the COVID 19 Vaccination Program for Children Aged 6-11 Years at Lhokseumawe, Aceh Province, Indonesia

International Journal of Advances in Social Sciences and Humanities, Journal Year: 2022, Volume and Issue: 1(4), P. 197 - 203

Published: Nov. 30, 2022

Implementation of the COVID-19 vaccine program in Muara Dua Regency for children aged 6 to 11 years is responding Covid-19 outbreak by Ministry Health. It initiated a vaccination expand reach national program. Minister health regulation number 18 2021 which regulates implementation immunization context handling 2019 corona virus disease (COVID 19) pandemic has this clause. The city Lhokseumawe complies with schedule from central government. For years, socialization been carried out improve performance all elements so that they can suppress growth Covid 19. In order achieve goal reducing spread COVID 19 generation children, cooperation related parties out. useful vaccinating years. This collaboration supports and strengthens each other. Human resources play key role driving policy because act as driver. Lack adequate information, training or human resource competencies contributes frequent failure implementation. have greatest impact on efficiency quality execution. FORKOPIMCAM sees initiative behind initiative. To make child vaccines successful, public must be informed about utilize available

Language: Английский

---

Implementor Involvement In Increasing Children’s Immunity During A Pandemic In Muara Dua Sub-District

Proceedings of International Conference on Social Science Political Science and Humanities (ICoSPOLHUM), Journal Year: 2022, Volume and Issue: 3, P. 00015 - 00015

Published: Dec. 21, 2022

Vaccination programme for children aged 6 to 11 in Muara Dua District, Lhokseumawe City: readiness of essential stakeholders and parents increase children's immune protection. Decree the Republic Indonesian Minister Health (KMK) Number HK.01.07./MENKES/6688/2021. The Covid-19 vaccine is only given school settings during pandemic intended prevent between ages from being exposed virus provide them with safety face-to-face learning (PTM). City executes detonation accordance directives federal government. Many youngsters have received vaccines. cooperation support appropriate parties crucial successful implementation this strategy. Qualitative application research methods, informants were determined purposively by considering criteria. Using observation, interviews, documentation obtain data. Implementation a child immunization program actually requires participation various parties. Based on findings, implementers has been successful, as evidenced bringing their open service positions mental strength implementers. Safe vaccination services are provided children.

Language: Английский

---